| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Revenue | $434.6M | +6.5% |
| Cost of Revenue | $295.2M | +12.1% |
| Gross Profit | $139.4M | -3.7% |
| R&D Expense | $35.8M | -1.8% |
| SG&A Expense | $89.5M | +5.2% |
| Operating Income | $10.6M | -45.5% |
| Pre-tax Income | $3.6M | -78.8% |
| Income Tax | $2.2M | -63.6% |
| Net Income | $1.3M |
| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.7M | -7.6% |
| Accounts Receivable | $180.3M | +14.1% |
| Current Assets | $463.6M | +14.4% |
| Total Assets | $633.3M | +18.3% |
| Current Liabilities | $282.2M | +28.9% |
| Long-term Debt | $87.6M | +81.2% |
| Total Liabilities | $370.1M | +32.5% |
| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.7M | -81.3% |
| Capital Expenditures | $13.0M | +384.9% |
| Investing Cash Flow | -$28.5M | +19.0% |
| Financing Cash Flow | $18.7M | -61.6% |
| Free Cash Flow | -$7.2M | -126.0% |
| -87.5% |
| EPS (Basic) | $0.11 | -87.5% |
| EPS (Diluted) | $0.10 | -88.4% |
| Stockholders' Equity |
| $263.2M |
| +2.9% |